| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/12/2009 | WO2009019656A1 Pyridyl derivatives, their preparation and use |
| 02/12/2009 | WO2009019149A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 02/12/2009 | WO2008152073A3 Piperazine compounds with a herbicidal action |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090042227 Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use |
| 02/12/2009 | CA2695331A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 02/11/2009 | EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 02/11/2009 | EP2021333A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 02/11/2009 | EP2021329A1 Inhibitors of c-fms kinase |
| 02/11/2009 | EP2021327A2 Antidiabetic bicyclic compounds |
| 02/11/2009 | CN101365684A Indazole derivatives that inhibit trpv1 receptor |
| 02/11/2009 | CN101362744A Sialic acid analogue and application thereof in anti-influenza virus medicament |
| 02/10/2009 | US7488811 Lacking cladinose in position 3, de(N-methyl)-descladinosyl-9-dihydro-erythromycin A; free of antibiotic properties; diseases related to an impaired cellular functionality of neutrophils, for instance rheumatoid arthritis, reperfusion ischaemia injury, septic shock, atherosclerosis |
| 02/10/2009 | US7488752 Thrombin receptor antagonists |
| 02/10/2009 | US7488742 Therapy for thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/05/2009 | WO2009016565A1 Tricyclic compounds for the treatment of inflammatory disorders |
| 02/05/2009 | WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/05/2009 | WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 02/05/2009 | US20090036691 Analogs of dicodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
| 02/05/2009 | US20090036439 5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one; bacterial cell wall biosynthesis via the Mur enzyme pathway; bactericides; paraciticides; nematocides; antibiotic-resistant diseases; agiculture; veterinary medicine |
| 02/05/2009 | CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/04/2009 | EP2020407A1 2-oxetanone derivative and process for production thereof |
| 02/04/2009 | EP2019679A2 Glucose transport inhibitors and methods of use |
| 02/04/2009 | CN101360499A Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 02/04/2009 | CN101357902A Method for preparing N- formyl-2H-4chloroquinoline derivate |
| 02/03/2009 | US7485641 Substituted 3-amino-pyrrolidino-4-lactams |
| 02/03/2009 | CA2352786C Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2008152159A3 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 01/29/2009 | US20090030202 Material for organic electroluminescent element and organic electroluminescent element employing the same |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/28/2009 | CN101356156A Aspartic protease inhibitors |
| 01/28/2009 | CN101353346A Puerarin amino acid ester derivative and medicine use thereof |
| 01/28/2009 | CN101353327A Aryl substituted pyrimidine spirobifluorene derivative and preparation thereof |
| 01/28/2009 | CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof |
| 01/22/2009 | WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | US20090023783 (2,4-Dichloro-phenyl)-(3-methyl-6-m-tolyl-benzofuran-2-yl)-methanone; anticarcinogenic, antiproliferative, antitumor agent; solid tumor, metastasis, lymphomas, leukemia; Cell Titre-Glo/High Throughput Assay |
| 01/22/2009 | US20090023140 Crosslinking agent, crosslinking method, method of controlling gene expression, and method of examining gene function |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/21/2009 | EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/21/2009 | EP1501791B1 Amino acid analogues |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/21/2009 | CN101348560A Epoxide resin containing furan group and preparation thereof |
| 01/21/2009 | CN101347473A Effective component of creat and preparation and use thereof |
| 01/21/2009 | CN100453538C Preparation for chemical composition of Shenmai injection and application in treating cardiovascular and cerebrovascular diseases thereof |
| 01/20/2009 | CA2521030C 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 01/20/2009 | CA2220759C 1,4-benzodioxin derivatives |
| 01/15/2009 | WO2009008980A2 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/15/2009 | WO2009008492A1 Process for producing macrolide compound and intermediate therefor |
| 01/15/2009 | US20090018354 Preparation of alpha-hydroxy and alpha-amino ketones |
| 01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018090 Process for preparation of anhydrous azithromycin |
| 01/15/2009 | CA2692644A1 Method for producing macrolide compound and production intermediate therof |
| 01/15/2009 | CA2691542A1 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/14/2009 | EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 01/14/2009 | CN101346367A Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof |
| 01/14/2009 | CN100451017C Method for preparing oxydiphthalic anhydrides using guanidinium salt as catalyst |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476647 1,5-dioxa-3-methyl-16-cyclohexadecanone; original odor characteristics, diffuses extremely well and is suitable for use as a fragrance, for example in cosmetic preparations, technical products or in alcoholic perfumery. |
| 01/08/2009 | WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
| 01/08/2009 | WO2008100867A3 Novel inhibitors hepatitis c virus replication |
| 01/08/2009 | US20090012291 Serotonin receptor agonists: 1-(2-aminoalkyl)-1H-furo(2,3-g)indazoles, e.g.,N-(3-hydroxy-2,2-dimethylpropyl)-1-((S)-2-aminopropyl)-1H-furo[2,3-g]indazole-7-carboxamide |
| 01/08/2009 | US20090012094 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 01/08/2009 | US20090012081 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/07/2009 | EP2010179A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 01/07/2009 | EP2010178A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 01/07/2009 | EP1797042B1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 01/07/2009 | CN100448871C Method for extracting nimbin |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/02/2009 | DE19819444B4 Dioxolan-Derivate, flüssigkristallines Medium und darauf basierende Anzeigeelemente Dioxolane derivatives, liquid crystalline medium based on it and display elements |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 12/31/2008 | WO2009001784A1 N-phenyl-methanamine derivative and pest control agent containing the same |
| 12/31/2008 | EP2009010A1 Cocrystal of c-glycoside derivative and l-proline |
| 12/31/2008 | EP2009007A1 Plant-derived therapeutic agent for malignant tumor |
| 12/31/2008 | EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 12/31/2008 | EP2007738A1 Diamino-1 ,3,5-triazines n-substituted with bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/30/2008 | US7470720 Antiproliferative agents; synergistic mixture of anticarcinogenic agents with antiemetic |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/24/2008 | WO2008125390A8 Extraction of theaflavins |
| 12/24/2008 | EP1603555B1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/24/2008 | EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 12/24/2008 | CN101328163A Compounds, compositions and methods |
| 12/24/2008 | CN101328135A Carbonyl phenyl propanoic acid derivative compounds |
| 12/23/2008 | US7468448 Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof |
| 12/23/2008 | US7468445 treating symptoms of one or more of the following medical conditions: amebic infections, giardiasis, estrogen deficient states, osteoporosis, cardiovascular heart disease, high cholesterol levels, hyperlipidemia, cancer by administering to a subject having, or predisposed to, one or more of the conditio |
| 12/23/2008 | US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |